EHAB vs. AVAH, AHCO, ADUS, ALDX, PAHC, LXRX, GHRS, BTAI, AUTL, and ZYME
Should you be buying Enhabit stock or one of its competitors? The main competitors of Enhabit include Aveanna Healthcare (AVAH), AdaptHealth (AHCO), Addus HomeCare (ADUS), Aldeyra Therapeutics (ALDX), Phibro Animal Health (PAHC), Lexicon Pharmaceuticals (LXRX), GH Research (GHRS), BioXcel Therapeutics (BTAI), Autolus Therapeutics (AUTL), and Zymeworks (ZYME). These companies are all part of the "medical" sector.
Enhabit vs.
Enhabit (NYSE:EHAB) and Aveanna Healthcare (NASDAQ:AVAH) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, community ranking, media sentiment and institutional ownership.
95.6% of Enhabit shares are owned by institutional investors. Comparatively, 91.7% of Aveanna Healthcare shares are owned by institutional investors. 1.9% of Enhabit shares are owned by company insiders. Comparatively, 6.9% of Aveanna Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Enhabit has a net margin of 3.64% compared to Aveanna Healthcare's net margin of -39.89%. Enhabit's return on equity of 6.59% beat Aveanna Healthcare's return on equity.
Enhabit has higher earnings, but lower revenue than Aveanna Healthcare. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Enhabit, indicating that it is currently the more affordable of the two stocks.
Enhabit presently has a consensus target price of $16.13, suggesting a potential upside of 35.05%. Aveanna Healthcare has a consensus target price of $4.84, suggesting a potential upside of 290.68%. Given Aveanna Healthcare's stronger consensus rating and higher possible upside, analysts plainly believe Aveanna Healthcare is more favorable than Enhabit.
In the previous week, Enhabit had 3 more articles in the media than Aveanna Healthcare. MarketBeat recorded 5 mentions for Enhabit and 2 mentions for Aveanna Healthcare. Enhabit's average media sentiment score of 0.49 beat Aveanna Healthcare's score of -1.00 indicating that Enhabit is being referred to more favorably in the media.
Aveanna Healthcare received 21 more outperform votes than Enhabit when rated by MarketBeat users. Likewise, 40.35% of users gave Aveanna Healthcare an outperform vote while only 14.29% of users gave Enhabit an outperform vote.
Summary
Enhabit beats Aveanna Healthcare on 10 of the 17 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EHAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools